Racial and gender trends in the use of implantable cardioverter-defibrillators among medicare beneficiaries between 1997 and 2003

Congestive Heart Failure

Volumn 15, Issue 2, 2009, Pages 51-57

  Chan, Paul S ^a   Birkmeyer, John D ^b   Krumholz, Harlan M ^c   Spertus, John A ^a   Nallamothu, Brahmajee K ^d  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; TREATMENT INDICATION; TREND STUDY;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; DEFIBRILLATORS, IMPLANTABLE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MALE; MEDICARE; MULTIVARIATE ANALYSIS; SEX FACTORS; UNITED STATES; UTILIZATION REVIEW;

EID: 65449145938     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2009.00060.x     Document Type: Article

References (23)

1. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
2. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction. N Engl J Med. 2002;346:877-883.
3. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
4. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-1890.
5. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576-1583.
6. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.
7. Chan PS, Chow T, Kereiakes D, et al. Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction. Arch Intern Med 2006;166:2228-2233.
8. Chan PS, Hayward RA. Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: An effectiveness study. J Am Coll Cardiol 2005;45:1474-1481.
9. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005;353:1471-1480.
10. Al-Khatib SM, Anstrom KJ, Eisenstein EL, et al. Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med 2005;142:593-600.
11. Voigt A, Ezzeddine R, Barrington W, et al. Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. J Am Coll Cardiol 2004;44:855-858.
12. Escarce JJ, Epstein KR, Colby DC, et al. Racial differences in the elderly's use of medical procedures and diagnostic tests. Am J Public Health 1993;83:948-954.
13. Vaccarino V, Rathore SS, Wenger NK, et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 2005;353:671-682.
14. Kressin NR, Petersen LA. Racial differences in the use of invasive cardiovascular procedures: Review of the literature and prescription for future research. Ann Intern Med 2001;135:352-366.
15. Jha AK, Fisher ES, Li Z, et al. Racial trends in the use of major procedures among the elderly. N Engl J Med 2005;353:683-691.
16. Schneider EC, Leape LL, Weissman JS, et al. Racial differences in cardiac revascularization rates: Does "overuse" explain higher rates among white patients? Ann Intern Med 2001;135:328-337.
17. Gauri AJ, Davis A, Hong T, et al. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med 2006;119:e17-e21.
18. Epstein AM, Ayanian JZ, Keogh JH, et al. Racial disparities in access to renal transplantation-clinically appropriate or due to underuse or overuse? N Engl J Med 2000;343:1537-1544, 1532 p preceding 1537.
19. Canto JG, Allison JJ, Kiefe CI, et al. Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. N Engl J Med 2000;342:1094-1100.
20. Rothman K, Greenland S. Modern Epidemiology, 2nd edn. Philadelphia, PA: Lippincott-Raven Publishers; 1998:260-262.
21. Groeneveld PW, Heidenreich PA, Garber AM. Trends in implantable cardioverter-defibrillator racial disparity: The importance of geography. J Am Coll Cardiol 2005;45:72-78.
22. Hernandez AF, Fonarow GC, Liang L, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 2007;298:1525-1532.
23. Rathore SS, Krumholz HM. Differences, disparities, and biases: clarifying racial variations in health care use. Ann Intern Med 2004;141:635-638.